Duloxetine (marketed as Cymbalta) Information
Duloxetine (marketed as Cymbalta) is included in the class of drugs called selective serotonin/norepinephrine reuptake inhibitors (SNRIs). This class of drugs is used to treat depression, anxiety, and other mood disorders.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program, using the contact information at the bottom of this page.
Related Information
- Antidepressant Use in Children, Adolescents, and Adults
- Understanding Antidepressant Medications
- Information for Healthcare Professionals: Duloxetine (marketed as Cymbalta) - Selective Serotonin Reuptake Inhibitors (SSRIs) or Selective Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) and 5-Hydroxytryptamine Receptor Agonists (Triptans)
- Public Health Advisory - Combined Use of 5-Hydroxytryptamine Receptor Agonists (Triptans), Selective Serotonin Reuptake Inhibitors (SSRIs) or Selective Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs) May Result in Life-threatening Serotonin Syndrome
- Historical Information on Duloxetine Hydrochloride (marketed as Cymbalta)